High Purity Pharmaceutical Qib 877399-52-5 Crizotinib rau Kev Kho Mob Cancer
Khoomnpe | Crizotinib |
Synonyms | PF-02341066;3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]pyridin-2-amine;TIAB SA 2341066 |
CAS Nr. | 877399-52-5 |
Qhov tshwm sim | Dawb mus rau dawb crystalline hmoov |
Molecular Formula | C21H22Cl2FN5O |
Molecular Luj | 450.34 Nws |
Kev siv | Pharmaceutical Qib lossis Kev Tshawb Fawb Lub Hom Phiaj |
Ntim | Raws li koj qhov kev thov |
Cia | Khaws nyob rau hauv nruj, lub teeb-resistant ntim nyob rau hauv ib qhov chaw txias |
CrizotinibCas: 877399-52-5 | ||
Cov khoom | Specifications | Cov txiaj ntsig |
Qhov tshwm sim | Dawb mus rau dawb crystalline hmoov | Dawb crystalline hmoov |
Kev txheeb xyuas | H-NMR, MS | Ua raws |
Residual Solvents | isopropanol ≤0.5% EOAc≤0.5% THF≤ 0.072% n-Heptane ≤0.5% Toluene ≤0.5% | 0.3% ND ND ND ND ND |
Hnyav Hlau | ≤10ppm | Ua raws |
Cov ntsiab lus dej | £ 0.5% | 0.3% |
Residue ntawm ignition | £ 0.5% | 0.05% |
Enantiomer | £ 0.1% | <LOQ |
Related Impurity los ntawm HPLC | Ib qho impurity≤0.1% Tag nrho impurity ≤1.0% | 0.05% 0.12% |
Purity (HPLC) | ³ 99.0% | 99.88% |
Cov ntaub ntawv tuam txhab
√ Kev tswj cov txheej txheem tag nrho hauv lub Hoobkas thiab cov kws tshaj lij cov neeg ua haujlwm; √ Zoo yog ib txwm peb xav txog sab saum toj, nruj QC system; √ 11 xyoo dhau los ntawm pab pawg muag khoom; √ Kev ywj pheej R & D lab; √ Ob qhov kev kos npe mus sij hawm ntev GMP kev cob qhia; √ Cov peev txheej nplua nuj ntawm ntau lub chaw ua haujlwm tsis ua haujlwm rau qhov project customized; √ Pab neeg ua haujlwm siab ua haujlwm nrog txoj hauv kev zoo ib yam.Sau koj cov lus ntawm no thiab xa tuaj rau peb